A New Era of Biosimilar Interchangeability Starts Now
Biologic prescribing is on the brink of transformation—and your workflow stands to benefit.
In June 2024, the FDA released its draft guidance titled “Considerations in Demonstrating Interchangeability,” signaling a major shift in how pharmacies can automatically substitute interchangeable biosimilars. This move simplifies how interchangeable biosimilars, like alternatives to Humira and Stelara, reach patients—bypassing hurdles that once delayed therapy and swelled administrative costs.
With more than 40 biosimilars now FDA-licensed and recent market entries slashing prices by over 50% (January–May 2025 data), it’s no longer a question of if your patients will transition—it’s how smoothly that switch will happen.
Al Excellence Pharmacy’s AEP Advantage Package ensures it’s seamless.
Why It Matters: Interchangeability, Efficiency, and Economics
Traditionally, switching a patient to a biosimilar required extra paperwork, callbacks, and EMR tweaks. Not anymore.
Thanks to the 2024 FDA guidance, interchangeable biosimilars can now be auto-substituted at the pharmacy level in many cases—no extra signatures, no new scripts, no delays.
What this means for you:
- Fewer call-backs.
- Fewer prior auth requests.
- And a major drop in specialty copays.
But there’s a catch: Only pharmacies equipped for this transition can guarantee those savings reach your patients without burdening your staff.
The AEP Advantage Package: Built for Your Workflow
Al Excellence Pharmacy’s AEP Advantage Package is designed with physicians in mind, especially in light of the 2025 biosimilar boom.
1️⃣ BioFast™ Mapping: No More EMR Guesswork
We proactively map your EMR drug library to the interchangeable biosimilars we stock—so your e-scripts align automatically with FDA-approved substitutions.
✅ Reduces 90% of pharmacy clarification calls
✅ Supports accurate, automated dispensing
✅ Keeps your charting clean and compliant
2️⃣ Real-Time Copay Feedback in Chart
Know your patient’s out-of-pocket cost before they leave your exam room. Our system feeds real-time copay data right back into your EMR.
✅ Improve adherence with up-front transparency
✅ Reduce post-visit price shock
✅ Document financial discussions for compliance
3️⃣ Nurse Coaching That Saves MA Time
Our specialty-trained nurses (available virtually or on-site) onboard patients to new biologics—removing confusion and saving your medical assistants valuable time.
✅ Biosimilar self-injection education
✅ Ongoing support via phone or video
✅ Higher patient satisfaction and reduced callbacks
4️⃣ Monthly Savings Dashboard
You’ll get a monthly snapshot of savings generated for your practice and patients—including:
- Total patient dollars saved
- Number of prior authorizations avoided
- Estimated time saved in call-backs and clarifications
Perfect for payer meetings or internal performance reviews.
Why Pick Al Excellence? Because We Let You Focus on Care
Al Excellence Pharmacy is the only New Jersey-based pharmacy that combines full biosimilar substitution services with provider-focused tech integration.
We’re already aligned with SureScripts. All you have to do is choose Al Excellence in your e-prescribing system—and we take care of the rest.
💡 CTA :
Pick Al Excellence in SureScripts; we do the substitution, you keep the visit flowing.
Stay Ahead of 2025’s Biggest Biologic Shift
As biosimilar adoption accelerates, providers who align with the right pharmacy partner will gain an edge—in savings, in patient satisfaction, and in reduced administrative strain.
To get your EMR mapped for BioFast™ and receive your first Savings Dashboard, contact Al Excellence Pharmacy today.
You can also call us at +1 (732) 448-9444 or email info@alexcellencepharmacy.com to start your onboarding.
